drugset / Trial / NCT03418233
Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Phase 2/3
Completed
115 enrolled
John Paul II Hospital, Krakow
KCRI · collabNational Center for Research and Development, Poland · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of the CIRCULATE project is to compare the clinical outcomes of CardioCell administration in treatment of ischemic damages of cardiovascular system with control group, who will receive the placebo.
Timeline
- Start
- 2018-04-19
- Primary completion
- 2021-01-27
- Completion
- 2021-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CardioCell | Cell therapy | 3e+07 cells | Other |